Unfortunately, the invasiveness of biopsy does not permit the sampling of primary tumours and metastases in regional lymph nodes and distant organs simultaneously, which might be critical because of HER2 expression heterogeneity between the primary tumour and metastatic sites (up to 40% of all cases) [5,6]. This evidence concerns the gene ERBB2 and neoplasm.